Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$558M |
| 2 |
Apple
AAPL
|
+$265M |
| 3 |
Microsoft
MSFT
|
+$209M |
| 4 |
Amazon
AMZN
|
+$197M |
| 5 |
Visa
V
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
COHR
Coherent Inc
COHR
|
+$86.3M |
| 2 |
TSMC
TSM
|
+$77.2M |
| 3 |
iShares MBS ETF
MBB
|
+$44.5M |
| 4 |
KSU
Kansas City Southern
KSU
|
+$43.8M |
| 5 |
Vale
VALE
|
+$28.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.97% |
| 2 | Financials | 12.67% |
| 3 | Consumer Discretionary | 11.32% |
| 4 | Healthcare | 10.27% |
| 5 | Communication Services | 7.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Incyte
INCY
$24.4B
| $2.98M | ﹤0.01% |
35,386
+606
| +2% | +$50.5K |
|
|
CDMO
427
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $2.94M | ﹤0.01% |
114,623
-1,054
| -0.9% | -$22.5K |
|
428
Regeneron Pharmaceuticals
REGN
$78.3B
| $2.88M | ﹤0.01% |
5,159
+44
| +0.9% | +$22.3K |
|
429
iShares Russell 1000 Growth ETF
IWF
$127B
| $2.87M | ﹤0.01% |
42,280
-3,228
| -7% | -$208K |
|
430
iShares Global Consumer Staples ETF
KXI
$1.06B
| $2.86M | ﹤0.01% |
46,781
-1,873
| -4% | -$114K |
|
431
J&J Snack Foods
JJSF
$1.47B
| $2.85M | ﹤0.01% |
16,364
+987
| +6% | +$167K |
|
432
Rexford Industrial Realty
REXR
$8.25B
| $2.8M | ﹤0.01% |
49,206
+7
| +0% | +$390 |
|
433
First Merchants
FRME
$2.73B
| $2.79M | ﹤0.01% |
66,919
+143
| +0.2% | +$6.53K |
|
434
IQVIA
IQV
$37.6B
| $2.75M | ﹤0.01% |
11,335
-714
| -6% | -$165K |
|
435
Installed Building Products
IBP
$6.41B
| $2.68M | ﹤0.01% |
21,918
-984
| -4% | -$120K |
|
436
Vanguard Total International Stock ETF
VXUS
$158B
| $2.66M | ﹤0.01% |
40,509
-17,609
| -30% | -$1.15M |
|
437
Verizon
VZ
$195B
| $2.62M | ﹤0.01% |
46,808
+2,176
| +5% | +$125K |
|
438
Expeditors International
EXPD
$23.7B
| $2.62M | ﹤0.01% |
20,700
-105
| -0.5% | -$12.4K |
|
439
State Street SPDR S&P 500 ETF Trust
SPY
$821B
| $2.59M | ﹤0.01% |
6,059
-1,301
| -18% | -$543K |
|
440
MYR Group
MYRG
$5.3B
| $2.58M | ﹤0.01% |
28,418
-330
| -1% | -$26.8K |
|
441
Snap-on
SNA
$21.6B
| $2.58M | ﹤0.01% |
11,551
-726
| -6% | -$174K |
|
|
SFBS
442
ServisFirst Bancshares
SFBS
$4.97B
| $2.58M | ﹤0.01% |
37,909
-2,239
| -6% | -$148K |
|
443
Advanced Drainage Systems
WMS
$11.5B
| $2.56M | ﹤0.01% |
21,954
| – | – |
|
|
CCMP
444
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $2.53M | ﹤0.01% |
16,771
+295
| +2% | +$48.9K |
|
445
T. Rowe Price
TROW
$24.7B
| $2.48M | ﹤0.01% |
12,546
-1,204
| -9% | -$225K |
|
446
iShares Europe ETF
IEV
$1.69B
| $2.48M | ﹤0.01% |
46,534
-2,017
| -4% | -$108K |
|
447
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.6B
| $2.44M | ﹤0.01% |
27,770
-146,650
| -84% | -$12.8M |
|
448
Teleflex
TFX
$6.2B
| $2.43M | ﹤0.01% |
6,045
+1,231
| +26% | +$504K |
|
449
Vanguard Morningstar Growth ETF
VUG
$230B
| $2.4M | ﹤0.01% |
50,304
+6,504
| +15% | +$295K |
|
450
Genpact
G
$6.07B
| $2.36M | ﹤0.01% |
51,944
-1,253
| -2% | -$56.7K |
|
Similar funds
Ken Fisher's Q2 2021 Portfolio in Review
As of Q2 2021, Ken Fisher held 1,100 positions worth $159B, up 12% from $142B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Ken Fisher deployed $4.92B of net new capital in Q2 2021, opening 101 new positions and adding to 388 existing holdings. Its largest new stake was Organon & Co: 967,460 shares worth $29.3M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was TSMC, an estimated $77.2M trimmed.
- Ken Fisher's largest Q2 2021 buy was Organon & Co: 967,460 shares worth $29.3M.
- Ken Fisher added most to Vanguard Intermediate-Term Corporate Bond ETF in Q2 2021, an estimated $558M increase.
- Ken Fisher's biggest Q2 2021 reduction was TSMC, cutting an estimated $77.2M.
- Ken Fisher fully exited Coherent Inc in Q2 2021, selling an estimated $86.3M.
- Ken Fisher's ten largest holdings make up 32% of its $159B portfolio in Q2 2021.
- Ken Fisher opened 101 new positions and closed 90 in Q2 2021.
- Ken Fisher's portfolio value rose 12% quarter-over-quarter to $159B.
Based on Fisher Asset Management's 13F filing for Q2 2021, filed 27 Jul 2021.